共 78 条
[1]
Society BC(2005)JBS 2: joint British societies’ guidelines on prevention of cardiovascular disease in clinical practice Heart 91 v1-v52
[2]
Society BH(2005)Effect of different antilipidemic agents and diets on mortality: a systematic review Arch Intern Med 165 725-730
[3]
Diabetes UK(1995)Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group N Engl J Med 333 1301-1307
[4]
Studer M(2013)Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 CD004816-269
[5]
Briel M(2013)Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER Atherosclerosis 228 265-423
[6]
Leimenstoll B(2008)The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies Clin Pharmacol Ther 84 417-1615
[7]
Glass TR(2011)Statin dose in Asians: is pharmacogenetics relevant? Pharmacogenomics 12 1605-1504
[8]
Bucher HC(2004)Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 1495-1718
[9]
Shepherd J(2001)Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 1711-375
[10]
Cobbe SM(2010)Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy Curr Med Res Opin 26 365-188